|
No.8826 2004. 6. 30
The World’s First Biotechnology — driven “Blue Roses”
— synonym for the impossible — have been successfully developed
SUNTORY LIMITED (Head Office:Osaka City, Japan / President:Nobutada Saji),
jointly with Florigene Ltd. (Victoria, Australia / President:Toshihiko Ashikari -
SUNTORY holds 98.5% of Florigene’s shares), has successfully developed the world’s
first biotechnology-driven “blue rose”.
Roses have been grown for a long time - 5,000 years or more. It is said that the varieties
developed to more than 25,000 species and a wide variety of colours exists including red,
white, pink and yellow. For a long time, breeders have been trying to develop blue roses,
which have long been synonym for the impossible.In an effort to achieve this breeders
have been crossing rose varieties grown all around the world. As a result, there are so-
called ‘blue’ roses already on the market. However, blue roses, derived from the
presence of blue pigment, have not yet come into being. It has been revealed that this is a
result of the fact that in rose petals genes encoding the enzyme that is necessary to create
the blue pigment, “Delphinidin”, are not functional (the enzyme is known as flavonoid
3’5’-hydroxylase).
SUNTORY has focused on this finding and, in 1990, in cooperation with an Australian
bio-venture company “Calgene Pacific (now: Florigene Ltd.) started the joint
development of biotechnology-driven “blue roses”. Since then we have been pursuing
our research attempting to develop “blue roses” by retrieving the genes necessary to
create blue pigments from other plants such as petunia and implanting these into roses.
The world’s first “blue carnations” were born in this development process in 1995 and, in
Japan, they were named “Moondust” where they have been marketed since 1997.
For the first time in the world, SUNTORY has succeeded in creating blue pigment in
roses by implanting the gene that leads to the synthesis of blue pigment from pansy.
Unlike the roses created by using conventional breeding technologies, the roses
developed by us have almost 100%* Delphinidin in their petals, which has allowed these
new and very different blue roses to become a reality. Although traditional roses have
only red pigments, by using the blue roses we have developed as a starting point, it is
expected that roses with the ability to create a blue pigment will soon lead more variety in
rose flower colour.
The SUNTORY GROUP will continue our research and development to make blue roses
“clearer”. The roses have been evaluated and approved based on the “Act concerning
Maintenance of Diversity of Organisms regulated by Use of Genetically-Modified
Organisms” (http://www.mext.go.jp/a_menu/shinkou/seimei/main.htm) and we will consider
merchandising after production, distribution, and sales structures have been properly
established.
The SUNTORY GROUP was established in 1899 and since then has been aggressively
developing new businesses maintaining its “spirit of challenge”. In this vein SUNTORY
opened the way for the successful marketing of well-known marks of “whisky”, “draft
beer”, and not being confined to producing alcoholic beverages, has also expanded into
the soft drink business, the flower business, the health food business, cultural and sports
activities. In addition business sphere has been expanded to Europe, Asia and North
America. We will continue our global business and efforts to create innovative products
showing our “spirit of challenge”.
(*) percentage of pigment content per 1g of petal
• Florigene Ltd.
| •Head Office |
16 Gipps Street,Collingwood,Victoria 3066, Australia |
| •CEO |
Toshihiko Ashikari |
| •Investment Ratio |
SUNTORY GROUP |
98.5% |
| Other |
1.5% |
Florigene. Ltd. was established as an Australian bio-venture company in 1986. It
develops new varieties of plants by using biotechnology. It is a world’s leading company
in the research of flower colour. SUNTORY LIMITED took over the company’s shares
in December, 2003.
|